Introduction Treatments for the acute respiratory distress syndrome (ARDS) are mainly
supportive, and ventilatory management represents a key approach in these patients …

Acute respiratory distress syndrome (ARDS) is a relatively common cause or complication of
critical illness. Despite 30 years of research, few interventions have impacted the course of …

Inflammatory processes during acute respiratory distress syn... : Current Opinion in Critical
Care Inflammatory processes during acute respiratory distress syndrome: a complex system …

Purinergic receptors of the P2 subclass are commonly found in human and rodent
macrophages where they can be activated by adenosine 5′-triphosphate (ATP) or uridine …

Acute respiratory distress syndrome (ARDS) is a life-threatening lung injury characterized by
an acute inflammatory response in the lung parenchyma. Hence, it is considered as the most …

Extracellular nucleotides have been recognized as important mediators of activation,
triggering multiple responses via plasma membrane receptors known as P2 receptors. P2 …

Dear Frontiers in Medicine reader, Acute respiratory distress syndrome (ARDS) and sepsis
remain leading causes of patient morbidity and mortality and the COVID-19 pandemic has …

Introduction Acute respiratory distress syndrome (ARDS) is a critical form of acute respiratory
failure characterized by diffuse alveolar damage, refractory hypoxemia, and non-cardiogenic …

RATIONALE: Rapidly improving Acute Respiratory Distress Syndrome (RIARDS) is a
recently described subgroup of ARDS in which hypoxemia significantly improves within 24 …